Hyperion Defi (HYPD) Return on Capital Employed (2018 - 2026)
Hyperion Defi (HYPD) posted quarterly Return on Capital Employed of 61.94% for Q1 2026, down 46587.0% year-over-year from N/an in Q1 2025, and up 14.39% quarter-over-quarter from 72.35% in Q4 2025.
Hyperion Defi (HYPD) Return on Capital Employed (2018 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Return on Capital Employed for 9 consecutive years, with 61.94% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 46587.0% year-over-year to 61.94%; the TTM figure through Mar 2026 stood at 61.94% (down 46587.0% YoY), while the FY2025 annual figure was 186.77%, up 2729313.0% from the prior year.
- Return on Capital Employed rose to 61.94% in Q1 2026 per HYPD's latest filing, from 72.35% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1731.82% in Q4 2024 and bottomed at 718.89% in Q3 2024.
- Historically, Return on Capital Employed has averaged 27.0% across 5 years, with a median of 91.21% in 2023.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 184579 bps — and 2025, when it plunged 180417 bps.
- Hyperion Defi's Return on Capital Employed stood at 100.76% in 2022, then slipped by 13 bps to 113.97% in 2023, then jumped by 1620 bps to 1731.82% in 2024, then sank by 104 bps to 72.35% in 2025, then grew by 14 bps to 61.94% in 2026.
- Business Quant data shows HYPD's Return on Capital Employed at 61.94% in Q1 2026, 72.35% in Q4 2025, and 40.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -38.20% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 26.09% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -50.93% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 7.88% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -6.85% |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 5.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.11% |
| Mar 31, 2026 | -61.94% |
| Dec 31, 2025 | -72.35% |
| Sep 30, 2025 | -40.51% |
| Jun 30, 2025 | -186.08% |
| Mar 31, 2025 | 403.94% |
| Dec 31, 2024 | 1,731.82% |
| Sep 30, 2024 | -718.89% |
| Jun 30, 2024 | -533.46% |
| Mar 31, 2024 | -274.22% |
| Dec 31, 2023 | -113.97% |
| Sep 30, 2023 | -91.21% |
| Jun 30, 2023 | -95.08% |
| Mar 31, 2023 | -99.65% |
| Dec 31, 2022 | -100.76% |
| Sep 30, 2022 | -82.20% |
| Jun 30, 2022 | -66.30% |
| Mar 31, 2022 | -58.10% |
| Dec 31, 2021 | -75.91% |
| Sep 30, 2021 | -286.94% |